HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Part of paid clinical trials in Chandler, Arizona.

Sponsor
Population Health Research Institute
Study ID
NCT04743765
Status
Recruiting

Conditions

  • Hip Fractures
  • Myocardial Injury

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Accelerated medical clearance and surgery — OTHER
    Rapid medical clearance with targeted arrival to the operating room within 6 hours of eligibility criteria criteria met.

Study Details

The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.

Key Dates

Start date
Nov 22, 2021
Status verified
Sep 2025
Primary completion
Feb 28, 2027
Completion
May 31, 2027

Study Design

Enrollment
1,100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Accelerated medical clearance and surgery
    Accelerated medical clearance and targeted arrival to the operating room within 6 hours of eligibility criteria met.
  • No Intervention: Standard surgical care
    Hip fracture repair and surgical care according to treating institution guidelines.

Primary Outcome Measure

All cause mortality [ Time Frame: Within 90 days post randomization ]

Central Contacts

Locations (19)

FacilityCityStateZIPSite coordinators
Chandler Regional Medical CenterChandlerArizona85224
Jessica Hummell
William Naylor, MD (PRINCIPAL_INVESTIGATOR)
The Regents of the University of CaliforniaDavisCalifornia95618
Julia Martin
Gaby Zumaran
Augustine Saiz, MD (PRINCIPAL_INVESTIGATOR)
Yale New Haven HospitalNew HavenConnecticut06520
Cecilia Lee
877-978-8343
Matthew Riedel, MD (PRINCIPAL_INVESTIGATOR)
Emory University at Grady Memorial HospitalAtlantaGeorgia30322
Morgan Fuller
Roberto Hernandez Irizarry, MD (PRINCIPAL_INVESTIGATOR)
Sinai Hospital of BaltimoreBaltimoreMaryland21215
Taj-Jamal Andrew, MD
Ronald Delanois, MD (PRINCIPAL_INVESTIGATOR)
University of MarylandBaltimoreMaryland20742
Heather Phipps
Gerard Slobogean, MD (PRINCIPAL_INVESTIGATOR)
Tufts Medical CenterBostonMassachusetts02111
Monica Hennessey
Scott Ryan, MD (PRINCIPAL_INVESTIGATOR)
Lahey Hospital and Medical CenterBurlingtonMassachusetts01805
Andrew Marcantonio, MD (PRINCIPAL_INVESTIGATOR)
University of MichiganAnn ArborMichigan48109
Lyle Johnson
Jaimo Ahn, MD (PRINCIPAL_INVESTIGATOR)
Mayo ClinicRochesterMinnesota55905
Gabriel Shouten
507-284-2511
Brandon Yuan, MD (PRINCIPAL_INVESTIGATOR)
Bryan Medical CenterLincolnNebraska68506
Kristin Williams
Bobbi Clinch
Steven Shannon, MD (PRINCIPAL_INVESTIGATOR)
University Medical Center of Southern NevadaLas VegasNevada89102
Robert Panganiban
Robert Bimbi
Erik Kubiak, MD (PRINCIPAL_INVESTIGATOR)
Dartmouth-Hitchcock Medical CenterLebanonNew Hampshire03756
Jon Mikael Anderson
Ida Leah Gitajn, MD (PRINCIPAL_INVESTIGATOR)
Montefiore Medical CenterThe BronxNew York10467
Leila Mehraban Alvandi
718-741-2426
Lauren Crocco, MD (PRINCIPAL_INVESTIGATOR)
Cleveland ClinicClevelandOhio44195
Laura Stiegel
Nicolas Piuzzi, MD (PRINCIPAL_INVESTIGATOR)
Oregon Health and Science UniversityPortlandOregon97239
Talia Trapalis
Zachary Working, MD (PRINCIPAL_INVESTIGATOR)
St. Luke's University Health NetworkBethlehemPennsylvania18015
Kyle McFadden
866-785-8537
Douglas Lundy, MD (PRINCIPAL_INVESTIGATOR)
The University of Texas Health Science Center at HoustonHoustonTexas77030
Sterling Boutte
Stephen Warner, MD (PRINCIPAL_INVESTIGATOR)
University of WisconsinMadisonWisconsin53715
Kristoffer Sladky
Christopher Domes, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chandler, AZ

Related Studies